Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, subcutaneous formulation, offers the potential for at-home administration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback